BioELife Corp. (LITH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -76.07 Thousand | -122.05 Thousand |
| Net Income | - | - | - | - | -336.95 Thousand | -246.85 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | 27.02 Thousand | 28.88 Thousand |
| Other non-cash items | - | - | - | - | 233.86 Thousand | 95.92 Thousand |
| Investing Cash Flow | - | - | - | - | 59.64 Thousand | - |
| Investments in PPE | - | - | - | - | -620.00 | - |
| Acquisitions | - | - | - | - | 60 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 266.00 | - |
| Other Investing Activities | - | - | - | - | 60 Thousand | - |
| Financing Cash Flow | - | - | - | - | 20 Thousand | 115 Thousand |
| Debt repayment | - | - | - | - | -20 Thousand | -115 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 20 Thousand | 115 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | 28.02 Thousand | 32.99 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | -1000.00 | -4110.00 |
| Cash at beginning of period | - | - | - | 4065.00 | 490.00 | 7540.00 |
| Cash at end of period | - | - | - | 4065.00 | 4065.00 | 490.00 |
| Capital Expenditure | - | - | - | - | -620.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | 3575.00 | -7050.00 |
| Free Cash Flow | - | - | - | - | -76.69 Thousand | -122.05 Thousand |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2019 Q3 | 2019 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | -48.41 Thousand | -106.15 Thousand |
| Depreciation & Amortization | - | - | - | - | 1152.00 | 296.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | -27.64 Thousand | -851.00 |
| Other non-cash items | - | - | - | - | 39.1 Thousand | 79.57 Thousand |
| Investing Cash Flow | - | - | - | - | 29.56 Thousand | 26.54 Thousand |
| Investments in PPE | - | - | - | - | -3498.00 | -5358.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 33.06 Thousand | 31.9 Thousand |
| Other Investing Activities | - | - | - | - | 33.06 | 31.90 |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | -13.64 Thousand | 10.88 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | -14 Thousand | -11.73 Thousand |
| Cash at beginning of period | - | - | - | 4065.00 | 20.98 Thousand | 21.57 Thousand |
| Cash at end of period | - | - | - | 4065.00 | 14.75 Thousand | 20.98 Thousand |
| Capital Expenditure | - | - | - | - | -3498.00 | -5358.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | -6228.00 | -589.00 |
| Free Cash Flow | - | - | - | - | -39.29 Thousand | -32.48 Thousand |
CLRCR
ENTRA
1405
605089
253840
VEDANTASSET